# Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

> **NCT01874457** · — · COMPLETED · sponsor: **The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)** · enrollment: 150 (actual)

## Conditions studied

- Mumps
- Rubella
- Measles

## Interventions

- **BIOLOGICAL:** MMR (Mumps, Measles and Rubella)

## Key facts

- **NCT ID:** NCT01874457
- **Lead sponsor:** The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-03
- **Final completion:** 2009-08
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2013-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01874457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01874457, "Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01874457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*